+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Emflaza"

Duchenne Muscular Dystrophy (DMD) Drugs Market Size, Share & Trends Analysis Report By Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy) And Segment Forecasts, 2018 - 2023 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Drugs Market Size, Share & Trends Analysis Report By Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy) And Segment Forecasts, 2018 - 2023

  • Report
  • August 2018
  • 77 Pages
  • Global
From
Duchenne Muscular Dystrophy - Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • October 2021
  • 250 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Emflaza is a market of drugs used to treat musculoskeletal disorders. These drugs are used to reduce pain, improve mobility, and reduce inflammation. They are often prescribed to people with conditions such as arthritis, osteoporosis, and fibromyalgia. Emflaza drugs are typically taken orally or injected, and can be used in combination with other treatments. They are designed to reduce the symptoms of musculoskeletal disorders and improve quality of life. The Emflaza market includes a variety of companies that produce and distribute these drugs. These companies include Pfizer, Merck, Novartis, and AbbVie. Other companies in the market include Amgen, Biogen, and Celgene. These companies are dedicated to providing safe and effective treatments for musculoskeletal disorders. Show Less Read more